Larvol Delta - CERo-Therapeutics-Holdings-Inc-Poised-to-Initiate-Enrollment-of-Phase-1-Trial-of-CER1236-in-AML-Following-Positive-FDA-Review-of-Manufacturing

CER-1236 - CERo Therap

https://www.globenewswire.com/news-release/2025/03/27/3050523/0/en/CERo-Therapeutics-Holdings-Inc-Poised-to-Initiate-Enrollment-of-Phase-1-Trial-of-CER-1236-in-AML-Following-Positive-FDA-Review-of-Manufacturing.html

Mar 27, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next